These findings highlight the important role of gut nesfatin-1 in the regulation of hepatic glucose metabolism and insulin response, suggesting that nesfatin-1 may be a promising novel therapeutic intervention for metabolic disorders. The gene discussed is NUCB2; the disease is Other metabolic disease.